World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
35521
World Ranking
10797
National Ranking
5556

Overview

H. Barton Grossman is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily falls under the field of Medicine, with significant contributions in Surgery, Molecular Biology, Economics and Econometrics, Oncology, and Rheumatology.

Their work focuses on several key topics, including:

  • Bladder and Urothelial Cancer Treatments
  • Urinary and Genital Oncology Studies
  • Epigenetics and DNA Methylation
  • Economic and Financial Impacts of Cancer
  • Cancer Immunotherapy and Biomarkers
  • Urologic and reproductive health conditions
  • Urological Disorders and Treatments

Grossman has published extensively, with frequent contributions to these venues:

  • The Journal of Urology
  • British Journal of Urology
  • Bladder Cancer

Some of their recent papers include:

  • "The obesity paradox: defining the impact of body mass index and diabetes mellitus for patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin" (2020), published in British Journal of Urology
  • "All High-Grade Ta Tumors Should Be Classified as High Risk: Bacillus Calmette-Guérin Response in High-Grade Ta Tumors" (2022), published in The Journal of Urology
  • "Time interval from transurethral resection of bladder tumour to bacille Calmette-Guérin induction does not impact therapeutic response" (2021), published in British Journal of Urology
  • "Impact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancer" (2021), published in British Journal of Urology
  • "North American study and meta-analysis evaluating performance of Bladder EpiCheck®, a FDA cleared test, in non-muscle invasive bladder cancer recurrence" (2024), published in Bladder Cancer

Collaboration is a significant aspect of Grossman's research, with frequent co-authors including:

  • Neema Navai
  • Colin P. Dinney
  • Nathan A. Brooks
  • Ashish M. Kamat
  • Kelly K. Bree

Best Publications

  • Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer

    H. Barton Grossman;Ronald B. Natale;Catherine M. Tangen;V.O. Speights

  • Epidemiology and risk factors of urothelial bladder cancer

    Maximilian Burger;James W.F. Catto;Guido Dalbagni;H. Barton Grossman

  • Mutations of the VHL tumour suppressor gene in renal carcinoma

    J.R. Gnarra;K. Tory;Y. Weng;L. Schmidt

  • Erratum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer (Nature Genetics (2009) 41 (991-995))

    Xifeng Wu;Yuanqing Ye;Lambertus A. Kiemeney;Patrick Sulem

  • A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder.

    Lamm Dl;Blumenstein Ba;Crawford Ed;Montie Je

  • Surgical Factors Influence Bladder Cancer Outcomes: A Cooperative Group Report

    Harry W. Herr;James R. Faulkner;H. Barton Grossman;Ronald B. Natale

  • Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers

    Vinata B. Lokeshwar;Tomonori Habuchi;H. Barton Grossman;William M. Murphy

  • Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data

    Maximilian Burger;H. Barton Grossman;Michael Droller;Joerg Schmidbauer

  • Detection of bladder cancer using a point-of-care proteomic assay.

    H. Barton Grossman;Edward Messing;Mark Soloway;Kevin Tomera

  • Amplification/Overexpression of a Mitotic Kinase Gene in Human Bladder Cancer

    Subrata Sen;Hongyi Zhou;Ruo Dan Zhang;Dong S. Yoon

  • A Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Carcinoma In Situ in Patients With Bladder Cancer: A Phase III, Multicenter Study

    Yves Fradet;H. Barton Grossman;Leonard Gomella;Seth Lerner

  • A Phase III, Multicenter Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Superficial Papillary Lesions in Patients With Bladder Cancer

    H. Barton Grossman;Leonard Gomella;Yves Fradet;Alvaro Morales

  • Renal cell carcinoma as an incidental finding.

    John W. Konnak;H. Barton Grossman

  • Evaluation of Genetic Variants in MicroRNA-Related Genes and Risk of Bladder Cancer

    Hushan Yang;Colin P. Dinney;Yuanqing Ye;Yong Zhu

  • Focus on bladder cancer

    Colin P.N. Dinney;David J. McConkey;Randall E. Millikan;Xifeng Wu

  • Clinical model of lifetime cost of treating bladder cancer and associated complications.

    Elenir B.C. Avritscher;Catherine D. Cooksley;H. Barton Grossman;Anita L. Sabichi

  • Bladder Cancer Predisposition: A Multigenic Approach to DNA-Repair and Cell-Cycle–Control Genes

    Xifeng Wu;Jian Gu;H. Barton Grossman;Christopher I. Amos

  • Hexaminolevulinate Guided Fluorescence Cystoscopy Reduces Recurrence in Patients With Nonmuscle Invasive Bladder Cancer

    Arnulf Stenzl;Maximilian Burger;Yves Fradet;Lance A. Mynderse

  • Surveillance for recurrent bladder cancer using a point-of-care proteomic assay.

    H. Barton Grossman;Mark Soloway;Edward Messing;Giora Katz

  • Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients.

    Ashish M. Kamat;Colin P. N. Dinney;Jason R. Gee;H. Barton Grossman

Frequent Co-Authors

Colin P. Dinney
Colin P. Dinney The University of Texas MD Anderson Cancer Center
Ashish M. Kamat
Ashish M. Kamat The University of Texas MD Anderson Cancer Center
Xifeng Wu
Xifeng Wu Zhejiang University
Bogdan Czerniak
Bogdan Czerniak The University of Texas MD Anderson Cancer Center
Wassim Kassouf
Wassim Kassouf McGill University
Louis L. Pisters
Louis L. Pisters The University of Texas MD Anderson Cancer Center
Jian Gu
Jian Gu The University of Texas MD Anderson Cancer Center
Seth P. Lerner
Seth P. Lerner Baylor College of Medicine
E. David Crawford
E. David Crawford University of California, San Diego
Margaret R. Spitz
Margaret R. Spitz Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to various online degrees and healthcare career options that provide flexibility and advancement. Many students and professionals interested in healthcare choose to pursue advanced credentials online for both convenience and affordability.

For those aiming for the highest roles in nursing leadership, the best online dnp programs offer rigorous training in clinical practice and health systems management. Pharmacists can expand their knowledge and career prospects through an online pharmd degree, which provides advanced clinical skills and specialized expertise.

If you're interested in the intersection of healthcare and technology, an online health information management degree prepares graduates to manage patient data, ensure data security, and support healthcare operations. Those seeking a quick entry into the industry may consider earning a medical coding certification online, a high-demand skill for managing healthcare records and billing.

These online programs offer diverse opportunities for those looking to begin or advance a rewarding career in healthcare.

Best Scientists Citing H. Barton Grossman

Trending Scientists